跳至主要内容
临床试验/NCT02161653
NCT02161653已完成4 期

Impact of Metadoxine in the Oxidative Stress and Early Mortality in Patients With Severe Alcoholic Hepatitis

Hospital General de Mexico1 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
135
试验地点
1
主要终点
30 day-survival

研究概览

简要总结

The purpose of this study is to determine whether metadoxine is effective for improve survival and reduced oxidative stress in patients with severe alcoholic hepatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with clinical and biochemical criteria for severe alcoholic hepatitis: Total bilirubin greater than 5 mg/dl in absence of biliary tract obstruction evidenced by ultrasound, history of chronic alcohol intake, leukocytosis, neutrophilia, elevation of transaminases with an aspartate aminotransferase / alanine aminotransferase ratio equal or greater than 2, discriminant function greater than 32.

排除标准

  • Diabetes, chronic kidney disease, hepatitis C, hepatitis B and or human immunodeficiency virus infection, asthma or history of atopy or allergic reactions, therapy in the previous two years with steroids, pentoxifylline, metadoxine, S-adenosyl L- methionine, antioxidants or multivitamins.

研究组 & 干预措施

Prednisone plus metadoxine

Experimental

Prednisone 40 mg daily by mouth plus Metadoxine 500 mg thrice in day by mouth during 30 days.

干预措施: Prednisone plus Metadoxine (Drug)

Pentoxifylline plus metadoxine

Experimental

Pentoxifylline 400 mg thrice in day by mouth plus Metadoxine 500 mg thrice in day by mouth during 30 days.

干预措施: Pentoxifylline plus Metadoxine (Drug)

结局指标

主要结局

30 day-survival

时间窗: 30 days

Malondialdehyde serum levels

时间窗: 14 and 30 days

次要结局

  • 3 month-survival(3 months)
  • 6 month-survival(6 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

MARIA DE FATIMA HIGUERA DE LA TIJERA

MD, MSc.

Hospital General de Mexico

研究点 (1)

Loading locations...

相似试验